Denali Therapeutics Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
64.33
|
|
Average Rating
|
4.53
|
|
# Strong Buys
|
11
|
|
# Buys
|
4
|
|
# Holds
|
2
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.81
|
-0.84
|
-0.03
|
-3.70%
|
|
2022-06-30
|
-0.55
|
-0.48
|
0.07
|
12.73%
|
|
2022-03-31
|
-0.51
|
-0.53
|
-0.02
|
-3.92%
|
|
2021-12-31
|
-0.41
|
-0.62
|
-0.21
|
-51.22%
|
|
2021-09-30
|
-0.47
|
-0.69
|
-0.22
|
-46.81%
|
|
2021-06-30
|
-0.41
|
-0.50
|
-0.09
|
-21.95%
|
|
2021-03-31
|
-0.34
|
-0.58
|
-0.24
|
-70.59%
|
|
2020-12-31
|
0.01
|
1.91
|
1.90
|
19000.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.85
|
|
2021-12-31
|
-2.39
|
|
2020-12-31
|
0.26
|
|
2019-12-31
|
-2.06
|
|
2018-12-31
|
-0.44
|
|
2017-12-31
|
-3.63
|